Sanofi’s Toujeo now available in the UK
4 August 2015 | By Victoria White
Toujeo is now available in the UK, providing another option for adults with type 1 and type 2 diabetes mellitus to help manage their condition...
List view / Grid view
News
FDA approves first ever 3D printed drug product: Spritam
4 August 2015 | By Victoria White
The FDA has approved 3D printed drug Spritam for the treatment of of partial onset seizures, myoclonic seizures and generalised tonic-clonic seizures...
Pfizer and Synthon enter commercialisation agreement
4 August 2015 | By Victoria White
Pfizer and Synthon have entered into an agreement whereby Pfizer has acquired the exclusive commercialisation rights in the US to glatiramer acetate...
FDA accepts Mundipharma EDO’s IND for EDO-S101
3 August 2015 | By Victoria White
The FDA has accepted Mundipharma EDO’s IND for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours...
Shire adds FST-100 to pipeline with Foresight acquisition
3 August 2015 | By Victoria White
Shire has acquired Foresight Biotherapeutics, gaining global rights to FST-100 - a therapy in development for the treatment of infectious conjunctivitis...
Celyad completes final patient infusion in Phase III trial of C-Cure
3 August 2015 | By Victoria White
Celyad has completed the injection procedure for the last patient enrolled in CHART-1, its Phase III clinical trial of cardiovascular candidate, C-Cure...
Cell Therapy Catapult awards major contract to CTL
3 August 2015 | By Victoria White
Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers...
Hope for pancreatic cancer urine test
3 August 2015 | By Victoria White
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...
Positive top-line results for Phase 3 telotristat etiprate study
3 August 2015 | By Victoria White
A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome...
World’s first international pharmaceutical seminar on Transmission Raman Spectroscopy
31 July 2015 | By Cobalt Light System
Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis...
Antibiotic resistance poorly communicated and widely misunderstood
31 July 2015 | By Victoria White
People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust...
Ebola vaccine found to have 100% efficacy in a Phase 3 trial
31 July 2015 | By Victoria White
Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial...
Eisai and Halozyme to investigate Halaven and PEGPH20 in metastatic breast cancer
31 July 2015 | By Victoria White
Eisai and Halozyme are to collaborate to evaluate Halaven in combination with PEGPH20 in first line HER2-negative metastatic breast cancer...
Roche submits filing to FDA for Cobas EGFR Mutation Test v2
31 July 2015 | By Victoria White
Roche submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the FDA, as a companion diagnostic test for AZD9291...
Eisai submits regulatory applications for eribulin in the US, EU and Japan
31 July 2015 | By Victoria White
Eisai has submitted regulatory applications in the US, EU and Japan for eribulin for the treatment of patients with inoperable soft tissue sarcoma (STS)...
